Dr. Katya (Ekaterina) Dolnikov, MD-PhD
Deputy Director of the Department of Internal Medicine and as a Senior Physician at the Rheumatology Institute
Clinical Expertise
Diagnosis and comprehensive management of a wide spectrum of autoimmune diseases and rheumatological disorders, including: Scleroderma, Systemic Lupus Erythematosus (SLE), Vasculitis, various types of Arthritis, Sarcoidosis, and Familial Mediterranean Fever (FMF).
Education & Academic Background
- MD-PhD Program: Graduated from the prestigious, integrated MD-PhD program at the Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology.
- International Fellowship: Completed an advanced professional fellowship at the renowned University Hospital Zurich (USZ) in Zurich, Switzerland.
- Medical Education & Leadership: Serves as the Coordinator for Internal Medicine Clinical Clerkships for Technion medical students, actively researching pedagogical innovations and digital teaching methodologies during crisis periods.
Core Research Areas
Dr. Dolnikov leads and contributes to groundbreaking clinical and basic science research published in leading international medical journals:
- Scleroderma & Pulmonary Complications: Investigating prognostic factors, morbidity, and mortality in Scleroderma patients with Interstitial Lung Disease (SSc-ILD), alongside microvascular and macrovascular endothelial function assessments.
- Experimental Cardiology & Stem Cells: Conducting basic science research on the physiological and biophysical properties of human embryonic stem cell-derived cardiomyocytes (heart cells).
- Clinical Manifestations of Sarcoidosis: Studying the multi-systemic (articular, cutaneous, and neurological) expressions of Sarcoidosis to optimize multidisciplinary
